AISAP Cardio vs Imbio RV/LV Software
AI Verdict
Choose AISAP Cardio if…
Choose AISAP Cardio if you require rapid, comprehensive cardiac diagnostic assessments directly at the patient's bedside using point-of-care ultrasound. This tool is ideal for early detection of a wide range of structural heart diseases and heart failure, providing automated measurements and interpretations of various cardiac parameters. It streamlines the workflow for immediate clinical decision-making in acute care settings.
View AISAP Cardio →Choose Imbio RV/LV Software if…
Choose Imbio RV/LV Software if your primary need is automated, precise measurement of right and left ventricular diameters from CTPA scans. This tool is specifically designed to calculate the RV/LV ratio, which is crucial for risk stratification in patients with suspected pulmonary conditions such as pulmonary embolism. It integrates seamlessly into existing radiology workflows, providing fully automated analysis without user intervention after scan completion.
View Imbio RV/LV Software →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AISAP Cardio | Imbio RV/LV Software |
|---|---|---|
| Deployment | Cloud-based | Cloud-based, Locally virtualized (virtual machine, Docker), or through partners like Aidoc, Blackford Analysis, and Philips Healthcare. [9, 27] |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AISAP CardioAISAP Cardio emphasizes empowering clinicians with basic scanning skills to perform rapid, comprehensive cardiac diagnostic assessments at the patient's bedside, making advanced POCUS more accessible. Its focus on point-of-care diagnosis directly supports immediate clinical decision-making.
Clinical Value
AISAP CardioBoth tools are FDA-cleared and offer valuable insights. However, AISAP Cardio provides a broader and more comprehensive cardiac diagnostic assessment, including LVEF, valvular pathologies, and various cardiac dimensions, enabling early detection of structural heart disease and heart failure. Clinical validation shows it enables non-cardiologists to achieve expert-level interpretations.
Pricing & Value
Imbio RV/LV SoftwareWhile neither tool provides explicit pricing, Imbio RV/LV Software offers a slightly clearer pricing model by stating it is 'subscription-based' and dependent on 'number of analyses, number of installations'. AISAP Cardio's pricing information is not publicly available and requires direct contact. [JSON]
Enterprise Readiness
Imbio RV/LV SoftwareImbio RV/LV Software explicitly states third-party HIPAA compliance certification and BAA availability, and offers flexible deployment options including cloud, on-premise, and integration with numerous partner platforms. This demonstrates a more robust and clearly articulated enterprise readiness compared to AISAP Cardio, where these aspects are only implied as likely. [JSON, cite: 8, 26]
Innovation
AISAP CardioAISAP Cardio's innovation is significant due to its pioneering FDA clearance for comprehensive POCUS diagnosis, enabling non-cardiologists to accurately interpret complex cardiac conditions at the bedside. This democratizes advanced cardiac diagnostics, making it accessible in diverse clinical settings and removing traditional technical barriers.
Support & Docs
Imbio RV/LV SoftwareImbio RV/LV Software provides explicit details about its 24/7/365 worldwide support, including phone and email contacts, and mentions the availability of user manuals and product documentation upon request. This level of detailed and accessible support information is not publicly available for AISAP Cardio.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AISAP Cardio | Imbio RV/LV Software |
|---|---|---|
| Description | FDA-cleared, AI-powered point-of-care ultrasound (POCUS) software platform for rapid, comprehensive cardiac diagnostic assessments and measurements, enabling early detection of structural heart disease and heart failure at the bedside. | AI-powered tool that automatically measures right and left ventricular diameters from CTPA scans, providing a ratio to aid in risk stratification for pulmonary conditions like pulmonary embolism. |
| Company | Aisap | Imbio |
| Specialties | Cardiology, Emergency Medicine, Radiology. | Cardiology, Pulmonology, Radiology. |
| Key Features | AI-powered interpretation for early cardiac disease detection; comprehensive cardiac ultrasound software package; automated generation of analyses, interpretations, and reports; assessment of valvular pathologies (mitral, tricuspid, aortic regurgitation, aortic stenosis); measurement of Left Ventricle Ejection Fraction (LVEF); measurement of right and left ventricular dimensions, atrial areas, ascending aorta diameter, and IVC diameter; vendor-agnostic and scalable solution; integration with existing clinical workflows, EHR/EMR, and PACS. | Automated measurement of right and left ventricular diameters; calculation and reporting of RV/LV ratio; artificial intelligence algorithm for ventricle identification and measurement; provides annotated images showing ventricular measurements; generates summary PDF reports; fully automated workflow, no user intervention required after scan completion; DICOM compliant input and output; integration with standard reading environments (PACS). |
Videos
Demos, reviews, and walkthroughs featuring AISAP Cardio and Imbio RV/LV Software.